English | Spanish
ecancer
Login Register

For the latest ecancer COVID-19 resources, click on this link

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Conferences
  • About us
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+ -
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [281]
News [921]
Articles [72]
Editorials [6]
Conferences [43]
elearning [16]
Impact of microbiome on head and neck cancers
Dr Young Jun Kim - Vanderbilt-Ingram Cancer Center, Nashville, USA
Impact of microbiome on head and neck cancers ( Dr Young Jun Kim - Vanderbilt-Ingram Cancer Center, Nashville, USA )
25 Apr 2018
Editor’s Choice for March 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor’s Choice for March 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
29 Mar 2018
A Zimbabwean perspective on radiotherapy in care and training
Dr Ntokozo Ndlovu - University of Zimbabwe, Harare, Zimbabwe
A Zimbabwean perspective on radiotherapy in care and training ( Dr Ntokozo Ndlovu - University of Zimbabwe, Harare, Zimbabwe )
22 Nov 2017
The promise of immunotherapy for elderly patients
Dr Alistair Greystoke - Newcastle University, Newcastle, UK
The promise of immunotherapy for elderly patients ( Dr Alistair Greystoke - Newcastle University, Newcastle, UK )
15 Nov 2017
Treatments for elderly head and neck cancer patients
Dr Ronald Maggiore - University of Rochester, New York, USA
Treatments for elderly head and neck cancer patients ( Dr Ronald Maggiore - University of Rochester, New York, USA )
15 Nov 2017
Editor's Choice for September 2017
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for September 2017 ( Prof Gordon McVie - Founding Editor, ecancer )
27 Sep 2017
Pembrolizumab falls short of endpoints in KEYNOTE 40
Dr Ezra Cohen - UC San Diego Health, San Diego, USA
Pembrolizumab falls short of endpoints in KEYNOTE 40 ( Dr Ezra Cohen - UC San Diego Health, San Diego, USA )
11 Sep 2017
Durvalumab in novel combinations for head and neck cancer
Dr Ezra Cohen - UC San Diego Health, San Diego, USA
Durvalumab in novel combinations for head and neck cancer ( Dr Ezra Cohen - UC San Diego Health, San Diego, USA )
11 Sep 2017
Treatment choices in thyroid cancer
Prof Makoto Tahara - National Cancer Center Hospital East, Kashiwanoha, Japan
Treatment choices in thyroid cancer ( Prof Makoto Tahara - National Cancer Center Hospital East, Kashiwanoha, Japan )
10 Sep 2017
Problems with survivorship care in Europe
Prof Francesco De Lorenzo - University of Naples Federico II, Naples, Italy
Problems with survivorship care in Europe ( Prof Francesco De Lorenzo - University of Naples Federico II, Naples, Italy )
9 Sep 2017
Underprovision and inequality of specialised cancer care
Dr Emmanouil Saloustros - General Hospital of Heraklion 'Venizelio', Crete, Gree...
Underprovision and inequality of specialised cancer care ( Dr Emmanouil Saloustros - General Hospital of Heraklion 'Venizelio', Crete, Greece )
9 Sep 2017
Regorafenib versus lomustine for relapsed glioblastoma
Dr Giuseppe Lombardi - Istituto Oncologico Veneto, Padova, Italy
Regorafenib versus lomustine for relapsed glioblastoma ( Dr Giuseppe Lombardi - Istituto Oncologico Veneto, Padova, Italy )
9 Sep 2017
<1234567...24>
Donate to ecancer

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
The content on this site is intended for healthcare professionals only
  • Follow ecancer on Facebook
  • Follow ecancer on Twitter
  • Follow ecancer on Linkedin
  • Subscribe to the ecancer YouTube channel
© 2021 ecancer, all rights reserved
UK registered charity number: 1176307